Cambridge Investment Research Advisors, Inc. Omeros Corp Transaction History

Cambridge Investment Research Advisors, Inc.

$26 Billion
Q1 2024

A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 14,743 shares of OMER stock, worth $57,350. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,743

Previous 14,143 4.24%

Holding current value

$57,350

Previous $46,000 10.87%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$2.88 - $4.89 $1,728 - $2,934	600 Added 4.24%	14,743 $51,000
Q4 2023 Feb 09, 2024	SELL	$1.08 - $3.63 $35,888 - $120,624	-33,230 Reduced 70.15%	14,143 $46,000
Q3 2023 Oct 24, 2023	SELL	$2.81 - $5.69 $160 - $324	-57 Reduced 0.12%	47,373 $138,000
Q2 2023 Jul 13, 2023	SELL	$4.45 - $7.57 $31,746 - $54,004	-7,134 Reduced 13.07%	47,430 $258,000
Q1 2023 May 11, 2023	SELL	$2.48 - $5.22 $1,297 - $2,730	-523 Reduced 0.95%	54,564 $254,000

Q4 2022 Feb 08, 2023	BUY	$1.75 - $3.96 $30,800 - $69,696	17,600 Added 46.95%	55,087 $124,000
Q2 2022 Jul 13, 2022	BUY	$1.92 - $6.28 $18,144 - $59,346	9,450 Added 33.71%	37,487 $103,000
Q1 2022 May 12, 2022	SELL	$5.07 - $7.2 $33,193 - $47,138	-6,547 Reduced 18.93%	28,037 $168,000
Q4 2021 Feb 03, 2022	SELL	$5.67 - $8.54 $29,540 - $44,493	-5,210 Reduced 13.09%	34,584 $222,000
Q3 2021 Nov 02, 2021	BUY	$13.4 - $16.3 $51,549 - $62,706	3,847 Added 10.7%	39,794 $548,000
Q2 2021 Aug 10, 2021	BUY	$14.81 - $19.13 $88,860 - $114,780	6,000 Added 20.04%	35,947 $533,000
Q1 2021 May 07, 2021	SELL	$14.52 - $23.53 $98,736 - $160,004	-6,800 Reduced 18.5%	29,947 $533,000
Q4 2020 Feb 04, 2021	SELL	$10.14 - $15.19 $13,891 - $20,810	-1,370 Reduced 3.59%	36,747 $525,000
Q3 2020 Oct 29, 2020	BUY	$9.57 - $21.32 $150,536 - $335,363	15,730 Added 70.26%	38,117 $385,000
Q2 2020 Jul 27, 2020	SELL	$12.21 - $16.99 $17,899 - $24,907	-1,466 Reduced 6.15%	22,387 $329,000
Q1 2020 May 08, 2020	BUY	$9.03 - $19.72 $45,691 - $99,783	5,060 Added 26.92%	23,853 $318,000
Q4 2019 Feb 04, 2020	BUY	$13.01 - $17.15 $50,739 - $66,885	3,900 Added 26.19%	18,793 $264,000
Q3 2019 Nov 06, 2019	SELL	$14.55 - $20.56 $68,385 - $96,632	-4,700 Reduced 23.99%	14,893 $243,000
Q2 2019 Aug 15, 2019	BUY	$15.0 - $19.62 $23,145 - $30,273	1,543 Added 8.55%	19,593 $0
Q1 2019 May 08, 2019	BUY	$11.65 - $17.72 $9,320 - $14,176	800 Added 4.64%	18,050 $0
Q4 2018 Feb 05, 2019	BUY	$10.72 - $16.73 $44,488 - $69,429	4,150 Added 31.68%	17,250 $192,000
Q3 2018 Nov 02, 2018	SELL	$17.73 - $26.69 $60,193 - $90,612	-3,395 Reduced 20.58%	13,100 $0
Q2 2018 Aug 10, 2018	BUY	$10.79 - $24.44 $18,343 - $41,548	1,700 Added 11.49%	16,495 $0
Q1 2018 May 09, 2018	SELL	$9.0 - $20.16 $17,550 - $39,312	-1,950 Reduced 11.65%	14,795 $0
Q4 2017 Feb 22, 2018	BUY	$13.26 - $22.86 $64,974 - $112,014	4,900 Added 41.37%	16,745 $0
Q3 2017 Nov 07, 2017	BUY	$19.76 - $24.9 $234,057 - $294,940	11,845	11,845 $256,000

Others Institutions Holding OMER

# of Institutions

107

Shares Held

26M

Call Options Held

299K

Put Options Held

520K

View Full List

About OMEROS CORP

Ticker OMER
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,730,000
Market Cap $244M
Description
Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...

More about OMER

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cambridge Investment Research Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cambridge Investment Research Advisors, Inc. with notifications on news.

Account

Cambridge Investment Research Advisors, Inc. Omeros Corp Transaction History